ARTICLE | Company News
Bayer submits vardenafil NDA
September 25, 2001 7:00 AM UTC
Bayer (FSE:BAYG) submitted an NDA to the FDA for vardenafil to treat erectile dysfunction. Bayer said it plans to launch vardenafil, an oral selective phosphodiesterase-5 ( PDE5) inhibitor, in the sec...